NCT02205554View on ClinicalTrials.gov

Omnitram Pharmacokinetic Study In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Pain
Interventions
DRUG

Omnitram

Nine 20 mg doses administered every 6 hours

DRUG

Tramadol

Nine 50 mg doses administered every 6 hours.

DRUG

Placebo

Nine doses administered every 6 hours.

Trial Locations (1)

84106

CRI Lifetree Research Center, Salt Lake City

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Syntrix Biosystems, Inc.

INDUSTRY

NCT02205554 - Omnitram Pharmacokinetic Study In Healthy Volunteers | Biotech Hunter | Biotech Hunter